Bad data is driving fear of a second wave of Covid-19

The recent spike in Covid-19 “cases” is very different to the original outbreak, says James Ferguson of MacroStrategy Partnership. The government needs to calm down.

Covid-19 cases are on the rise again, particularly amongst the young. The “rule of six” is now nationwide. Localised lockdowns are in place up north. And even martial-law-style 10pm curfews are being considered. So-called “pillar 2” cases from the wider community – where “cases” are a misnomer for “positive” test results – have doubled in the last two weeks from about 2% to roughly 4%. Is this the long-awaited second wave? And once all these infected young northerners visit their grandfathers (ill, elderly men are particularly vulnerable), will it turn into an increase in deaths too? 

This seems to be what our politicians fear – hence their aggressive response. However they are making some major mistakes. One is the policy direction itself – the correct response is not a lockdown of the general population, but shielding of the vulnerable. The other is in misinterpreting the data. “Positives” are not the same as “cases” (the latter require both symptoms and a doctor’s diagnosis).

This leads to a dilemma because, as you can see from the chart on page 23 (which runs to 12 September), although positives have leapt sevenfold from their June-July low, deaths over the same period have fallen by two thirds. 

The epidemiological rule-of-thumb is that the number of (unseen) infections will be roughly ten times the number of diagnosed cases, which in turn will be roughly ten times greater than the number of deaths. Working backwards from deaths, and taking account of the three-week period of illness, we would expect the UK to have about 2,500 diagnosed cases, of which half would be hospitalised (the government currently reports just 972 hospital patients). That would also suggest 25,000 current infections, or disease prevalence (ie, the percentage of the population who has it) of sub-0.04%.

Yet the pillar 2 community-testing scheme is now finding 4% positives. In other words, the test regime seems to be finding 100 times more positives than the combined data on diagnosed cases, hospital admissions and deaths would suggest. That begs the question: how many of these are false positives?

Why false positives really matter

It might surprise you to learn that a positive medical test result does not often – or even usually – mean that an asymptomatic patient has a disease. If the false positive rate (FPR) is the same as the prevalence of the disease, then half of all positives will be false. And the lower the prevalence compared to the FPR, the more inaccurate the results will be. Even doctors don’t tend to grasp the full implications of that.

In 1982, a researcher called David Eddy provided physicians with a diagnostic puzzle. Women age 40, participate in routine screening for breast cancer, with a prevalence of 1%. The mammogram test has a false negative rate of 20% and an FPR of 10%. What is the probability that a woman with a positive test has breast cancer? The correct answer is just 7.5%.

In each batch of 100,000 tests, 800 cases (80% of the 1,000 women who actually have breast cancer) will be picked up. But so too will 9,920 (10% FPR) of the 99,200 healthy women. So the chance of having breast cancer if you test positive is still only 7.46% (800/10,720). However, 95 out of 100 doctors gave answers in the range of 70-80%, ten times higher than the correct answer. 

Not a whole lot has changed since that study. 

To read the whole of this article, subscribe to MoneyWeek magazine

Subscribers can see the whole article in the digital edition available here

Recommended

Persimmon yields 12.3%, but can you trust the company to deliver?
Share tips

Persimmon yields 12.3%, but can you trust the company to deliver?

With a dividend yield of 12.3%, Persimmon looks like a highly attractive prospect for income investors. But that sort of yield can also indicate compa…
1 Jul 2022
The MoneyWeek Podcast: nuggets of positivity in an extended bear market
Investment strategy

The MoneyWeek Podcast: nuggets of positivity in an extended bear market

Merryn and John talk about he need for higher wages and lower house prices, and why the fact that this is the least dramatic bear market they’ve ever …
1 Jul 2022
Here are the best savings accounts on the market now
Savings

Here are the best savings accounts on the market now

With inflation at more than 9%, your savings are not going to keep pace with the rising cost of living. But you can at least slow the rate at which yo…
1 Jul 2022
Don’t try to time the bottom – start buying good companies now
Investment strategy

Don’t try to time the bottom – start buying good companies now

Markets are having a rough time, so you may be tempted to wait to try to call the bottom and pick up some bargains. But that would be a mistake, says …
1 Jul 2022

Most Popular

UK house prices are definitely cooling off – but are they heading for a fall?
House prices

UK house prices are definitely cooling off – but are they heading for a fall?

UK house prices hit a fresh high in June, but as interest rates start to rise, the market is cooling John Stepek assesses just how much of an effect h…
30 Jun 2022
The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
22 Jun 2022
The ten highest dividend yields on Aim
Income investing

The ten highest dividend yields on Aim

Rupert Hargreaves picks the highest-paying dividend stocks on Aim, London’s junior market for small and medium-sized growth companies.
29 Jun 2022